Thromboprophylaxis with dabigatran etexilate in patients over seventy-five years of age with moderate renal impairment undergoing or knee replacement

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II)

(2011) Ola Dahl et al.   THROMBOSIS AND HAEMOSTASIS

Physicians’ perceptions of the definition of major bleeding in major orthopedic surgery: results of an international survey

(2010) Enrique Ginzburg et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients

(2009) Alexander GG Turpie et al.   BLOOD COAGULATION & FIBRINOLYSIS

State-of-the-Art Review: Assessing the Safety Profiles of New Anticoagulants for Major Orthopedic Surgery Thromboprophylaxis

(2009) Russell D. Hull et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Interpretation of Benefit-Risk of Enoxaparin as Comparator in the RECORD Program: Rivaroxaban Oral Tablets (10 milligrams) for Use in Prophylaxis in Deep Vein Thrombosis and Pulmonary Embolism in Patients Undergoing Hip or Knee Replacement Surgery

(2009) David Van Thiel et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Editorial Board

(2009)   JOURNAL OF ARTHROPLASTY

Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement

(2009) B. I. Eriksson et al.   JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME

Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin DalteparinAn Assessment of Safety and Pharmacodynamics: The DIRECT Study

(2008) James Douketis   ARCHIVES OF INTERNAL MEDICINE

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment

(2008) Sam Schulman et al.   CHEST

Prevention of Venous Thromboembolism

(2008) William H. Geerts et al.   CHEST